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Proteinase-activated receptors (PARs) are G-protein cou-
pled receptors with seven transmembrane domains that
are stimulated by a unique activation mechanism. The
extracellular N-terminus is specifically cleaved by certain
serine proteinases, which exposes a formerly latent pep-
tide sequence. This "tethered ligand" is able to bind to the
second extracellular loop of the receptor, leading to the
transduction of signal events. Four PARs have been cloned
so far. PAR1, PAR3 and PAR4 are stimulated by thrombin,
whereas PAR2 can be activated by trypsin. In vitro, PARs
can also be stimulated by synthetic peptides, which mimic
the tethered ligand sequence. PAR1, but not PAR2, is
expressed by primary melanocytes. It is well known that
PAR1 is overexpressed in malignant melanomas, enhanc-
ing migration and metastasis. PAR2 also seems to play a
role in melanoma progression and metastasis. The under-
lying mechanisms, however, still remain elusive. Stimula-
tion of both receptors on the the human melanoma cell
line WM9 led to rearrangement of integrin αvβ3 and
phosphorylation of protein kinase D1 (PKD1). PKD1 is
known to control persistent cell migration by regulating
the intracellular integrin αvβ3 recycling pathway. Stable
knockdown of PKD1 in WM9 cells led to an inhibition of
cell proliferation, changes in cell shape and a downregu-
lation of integrin αvβ3 on the cell surface. Moreover, cell
migration was impaired. Taken together, we could show
for the first time that both PAR1 and PAR2 are involved in
melanoma cell migration and proliferation via activation
of PKD1.
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